Arkolith/Insider Trading/TNGX/Form 4

TRV GP IV, LLC

10% OwnerTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Sep 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.0M
Net Open-Market Flow
-$4.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2025Sell(S)500K$8.02$4.0M13.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-223227) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML